1. Home
  2. PFSI vs ABCL Comparison

PFSI vs ABCL Comparison

Compare PFSI & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennyMac Financial Services Inc.

PFSI

PennyMac Financial Services Inc.

HOLD

Current Price

$75.30

Market Cap

4.0B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$11.06

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PFSI
ABCL
Founded
2008
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
3.5B
IPO Year
2018
2020

Fundamental Metrics

Financial Performance
Metric
PFSI
ABCL
Price
$75.30
$11.06
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$128.11
$8.40
AVG Volume (30 Days)
667.3K
8.2M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
1.35%
N/A
EPS Growth
59.25
10.91
EPS
1.94
N/A
Revenue
$984,629,000.00
$75,128,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$16.96
$21.85
P/E Ratio
$39.34
N/A
Revenue Growth
3.05
160.56
52 Week Low
$71.68
$2.75
52 Week High
$160.36
$11.65

Technical Indicators

Market Signals
Indicator
PFSI
ABCL
Relative Strength Index (RSI) 39.69 80.64
Support Level $71.68 $3.38
Resistance Level $87.46 N/A
Average True Range (ATR) 2.31 0.82
MACD -0.06 0.54
Stochastic Oscillator 45.78 92.37

Price Performance

Historical Comparison
PFSI
ABCL

About PFSI PennyMac Financial Services Inc.

PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform mainly focused on the production and servicing of U.S. residential mortgage loans. The firm is also engaged in managing investments related to the U.S. mortgage market and provides products and services that leverage technologies to support customers. The company operates through two reportable operating segments: production and servicing. The production segment performs loan origination, acquisition, and sale activities, while the servicing segment performs servicing and subservicing of loans, early buyout transactions, and servicing of loans sourced and managed for PMT. The majority of revenue comes from the production segment.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: